A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses

Vaccine

Volumn 20, Issue 1-2, 2001, Pages 158-163

  Rimmelzwaan, G F ^a   Baars, M ^a   Van Amerongen, G ^b   Van Beek, R ^a   Osterhaus, A D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Influenza A (H3N2) virus; ISCOM influenza vaccine; Vaccine strain

Indexed keywords

INFLUENZA VACCINE; ISCOM; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; DRUG SYNTHESIS; IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT OUTCOME; VIRUS STRAIN;

ANIMALS; ANTIGENIC VARIATION; ANTIGENS, VIRAL; DRUG EVALUATION; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; ISCOMS; MACACA FASCICULARIS; ORTHOMYXOVIRIDAE INFECTIONS; RECURRENCE; VACCINATION;

EID: 0035850965     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00262-6     Document Type: Article

References (22)

1. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A (H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly
2. ISCOMs: Materials, preparation, antigen delivery and immune response
3. Augmentation of human influenza A virus specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS)
4. A randomized, double blind study to compare the cell mediated and humoral immunogenicity of two influenza ISCOM vaccines with a conventional inactivated split virion vaccine in young healthy adults
5. Induction of protective immunity against influenza in a macaque model: Comparison of conventional and ISCOM vaccines
6. Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection and vaccination with an ISCOM-based vaccine
7. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
8. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche
9. Haemagglutination inhibition test
10. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus
11. ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus
12. Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes
13. Cytotoxic T cell immunity to influenza
14. Cytotoxic T lymphocyte memory: Role in cross-protective immunity against influenza?
15. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza
16. Contribution of virus specific CD8+ cytotoxic T cells to virus clearance or pathological manifestations of influenza virus infection in a T cell receptor trangenic mouse model
17. Resistance to and recovery from lethal influenza virus infection in B lymphocyte deficient mice
18. Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8+ cytotxic T lymphocytes
19. Original antigenic sin in ferrets: The response to sequential infection with influenza viruses
20. Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans
21. Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: Analysis of original antigenic sin by limiting dilution
22. Original antigenic sin to influenza in rats